Clinical Trial Update: A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating axatilimab plus corticosteroids as initial treatment for chronic graft-versus-host disease; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Axatilimab (axatilimab)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: Incyte Corporation | Conditions: Chronic Graft-versus-host-disease | Phase 3 | Status: RECRUITING